Amyotrophic lateral sclerosis Animals Muscle Trinucleotide repeat expansion COVID-19 Neuromuscular junction Rare neuromuscular diseases OPMD Motoneuron Biomarkers Transcriptomics Long read sequencing Cytokines RNA biology Muscle regeneration Dermatomyositis Therapy Congenital myopathy Neuromuscular diseases Antisense oligonucleotides Actin Myopathies Transgenic mouse model Glutamate Mice Regeneration Congenital muscular dystrophy Brain LMNA Aged Autoantibodies Genotype phenotype correlation Errance diagnostique Laminopathies Myopathy Dilated cardiomyopathy Skeletal muscle Myasthenia Gravis MG Rare diseases Myositis Thérapie génique Spinal muscular atrophy Lamin A/C MBNL Myasthenia gravis Dynamin 2 Laminopathie Heart failure Neuromuscular disease Inflammation Exercise PABPN1 Myotonic Dystrophy type 1 Autoimmune diseases Cytoskeleton Duchenne muscular dystrophy Myotonic dystrophy Mouse model AAV Laminopathy Biomarker Myogenesis Satellite cells Alternative splicing Lamin A/C LMNA gene Thymus FSHD Autophagy Gene therapy Fibrosis Satellite cell Mechanotransduction Becker muscular dystrophy Genetics Treatment Cell therapy Myotonic Dystrophy Myoblasts ALS Myotonic dystrophy type 1 CTG repeat contractions Centronuclear myopathy Muscular dystrophy Aging LMNA gene Calcium RNA interference Nuclear envelope Humans Astrocyte CMS DMD Autoimmunity Cardiomyopathy CRISPRi Dystrophin Male Outcome measures Fabry disease Heart